about
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvantCarbon nanotubes as vaccine scaffoldsIn silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans.Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.Laser vaccine adjuvant for cutaneous immunization.Directed antigen delivery as a vaccine strategy for an intracellular bacterial pathogen.Profiling antibody responses by multiparametric analysis of primary B cells.A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation.How B cells shape the immune response against Mycobacterium tuberculosis.The Role of Immunogenicity in Cardiovascular Disease.Proteomic studies of Bacillus anthracis.Current adjuvants and new perspectives in vaccine formulation.Adjuvants containing natural and synthetic Toll-like receptor 4 ligands.[Innovations in vaccinology: challenge and opportunities for Africa].Zymosan A enhances humoral immune responses to soluble protein in chickens.Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy.Stimulation of In Vivo Antitumor Immunity with Hollow Mesoporous Silica Nanospheres.Rod-shaped and fluorine-substituted hydroxyapatite free of molecular immunopotentiators stimulates anti-cancer immunity in vivo.Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.
P2860
Q21091066-5D102F5D-6937-423A-88AC-A70039DC25D4Q28392532-AA17BC48-1A01-4E33-8C08-5F182C49D74FQ30159564-F8CD6D32-8C0F-46FE-B73A-E2031855F71CQ33805176-8126ED18-E84B-4AA6-A746-0A9C5E70D4C6Q34046148-D44885C7-41FF-4202-B695-D669902DF82DQ34596940-7EFCC64B-C83A-4789-A164-DCA32A7B48B9Q34878648-9C1B57F7-75DA-4F13-B9CB-FACFE0B2E3BBQ36684447-E0811EEC-CA63-4C66-9B5C-AE3FA1E68397Q37383963-E9FBEB2E-68FE-4FB2-82A3-69E7A1A3B741Q37560012-C12EF908-89EA-4590-AFA6-7CA2F634C05FQ37613667-441E05DD-A6E2-4D0A-ADD9-86FD3D047A66Q37909424-EA3D030C-FF42-4DBE-91B8-76C419FB9CB2Q38124063-32A43810-CF1D-41B3-90FB-AD4099658340Q40142343-A45B65D6-1E7E-4856-8135-63EC47FF97D6Q40157097-E812D6A2-2C49-413A-A7E0-8CD9F95061FBQ42049992-1A6EE45B-DB12-4D15-8A18-35F9D6CF4FE9Q42819836-B9DBE4CB-1A2F-4C13-81EC-784556046472Q48128797-22163625-7B8D-4CB2-BFC7-9C8AF6986E3CQ53113580-224DD6A4-0D22-4F35-B858-47E5E575AF4DQ55326313-4B0F89B3-FCC8-445A-872C-3DC54AD988D9
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Vaccinology at the beginning of the 21st century.
@ast
Vaccinology at the beginning of the 21st century.
@en
type
label
Vaccinology at the beginning of the 21st century.
@ast
Vaccinology at the beginning of the 21st century.
@en
prefLabel
Vaccinology at the beginning of the 21st century.
@ast
Vaccinology at the beginning of the 21st century.
@en
P1476
Vaccinology at the beginning of the 21st century.
@en
P304
P356
10.1016/J.COI.2005.05.005
P577
2005-08-01T00:00:00Z